Agents and Actions

, Volume 13, Issue 5–6, pp 439–441 | Cite as

Diverging effects of activated serum on polymorphonuclear cell adherence

  • Thierry Appelboom
  • Michèle Delronche
  • Marianne Pierart
  • Robert Gortz
The Complement System: Formation, Activation and Modes of Action
  • 14 Downloads

Abstract

Activation products can be elicited from zymosan suspended in fresh serum. However, variations in experimental conditions modify dramatically the ability of serumtreated zymosan to modulate polymorphonuclear cell (PMN) adhesiveness. Indeed, serum treated by small amounts of zymosan reduces while large amounts enhance adhesiveness. When zymosan is boiled, smaller quantities are needed to obtain an effect similar to large ones.

Therefore, we can propose that not a unique factor like C5a but different activation products for PMN are elicited during treatment of serum by zymosan.

Keywords

Cell Adherence Activation Product Unique Factor Polymorphonuclear Cell Diverge Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    P.R. Craddock, D. Hammerschmidt, J.G. White, A.P. Dalmasso andH.S. Jacob,Complement (C5a)induced granulocyte aggregation in vitro, J. clin. Invest.60, 260–264 (1977).Google Scholar
  2. [2]
    J. Fehr andH.S. Jacob,In vitro granulocyte adherence and in vivo margination, J. exp. Med.146, 641–652 (1977).Google Scholar
  3. [3]
    H.S. Jacob, P.R. Craddock, D.E. Hammerschmidt andC. Moldow,Complement-induced granulocyte aggregation, New Engl. J. Med.302, 789–794 (1980).Google Scholar
  4. [4]
    J.M. Harlan, P.D. Killen L.A. Harker andG.E. Striker,Neutrophil-mediated endothelial injury in vitro: mechanisms of cell detachment, J. clin. Invest.68, 1394–1403 (1981).Google Scholar
  5. [5]
    T. Appelboom, A. Govaerts andJ. Wybran,The leukocyte adherence inhibition test in arthritis, Lancetii, 65–68 (1978).Google Scholar
  6. [6]
    T. Appelboom, N. Dourov, R. Görtz andJ. Wybran,Leukocyte adherence inhibition test: cellular requirements for the elaboration of a PMN adherence inhibition activity, Clin. Immunopathol.20, 63–70 (1981).Google Scholar

Copyright information

© Birkhäuser Verlag 1983

Authors and Affiliations

  • Thierry Appelboom
    • 1
  • Michèle Delronche
    • 1
  • Marianne Pierart
    • 1
  • Robert Gortz
    • 2
  1. 1.Service et Laboratoire de Rhumatologie, Hôpital ErasmeUniversité Libre de BruxellesBruxellesBelgium
  2. 2.Fondation Robert DebréBruxellesBelgium

Personalised recommendations